<DOC>
	<DOCNO>NCT02339818</DOCNO>
	<brief_summary>The main purpose evaluate effectiveness Eliquis® ( apixaban ) Prescriber Guide Patient Alert Card term knowledge important identify risk bleed associate Eliquis treatment communicate RM tool .</brief_summary>
	<brief_title>Evaluation Effectiveness Eliquis ® ( Apixaban ) Risk Minimization Tools European Economic Area ( EEA ) Countries</brief_title>
	<detailed_description>Observational Model , Other- This non-interventional , cross-sectional study EEA involve representative sample HCPs treat patient Eliquis , well patient treat Eliquis . This study facilitate via web-based survey use evaluate effectiveness Eliquis Prescribe Guide Patient Alert Card risk management tool . Enrollment : 384 Health Care Professions ( HCPs ) 192 Patients Treatment deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) prevention recurrent DVT PE adult ( VTEt ) Prevention VTE adult patient knee replacement surgery ( VTEp )</detailed_description>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com HCP must involve treatment least one patient Eliquis approve indication Patients must take Eliquis approve indication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>